[HTML][HTML] The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention

S Cambier, M Gouwy, P Proost - Cellular & Molecular Immunology, 2023 - nature.com
Chemokines are an indispensable component of our immune system through the regulation
of directional migration and activation of leukocytes. CXCL8 is the most potent human …

[HTML][HTML] Key chemokines direct migration of immune cells in solid tumors

K Kohli, VG Pillarisetty, TS Kim - Cancer gene therapy, 2022 - nature.com
Immune cell infiltration into solid tumors, their movement within the tumor microenvironment
(TME), and interaction with other immune cells are controlled by their directed migration …

[HTML][HTML] Role of the CXCL8-CXCR1/2 axis in cancer and inflammatory diseases

H Ha, B Debnath, N Neamati - Theranostics, 2017 - ncbi.nlm.nih.gov
The chemokine receptors CXCR1/2 and their ligand CXCL8 are essential for the activation
and trafficking of inflammatory mediators as well as tumor progression and metastasis. The …

Interleukin-8 in cancer pathogenesis, treatment and follow-up

C Alfaro, MF Sanmamed, ME Rodríguez-Ruiz… - Cancer treatment …, 2017 - Elsevier
Abstract Interleukin-8 (CXCL8) was originally described as a chemokine whose main
function is the attraction of a polymorphonuclear inflammatory leukocyte infiltrate acting on …

[HTML][HTML] The IL-8/IL-8R axis: a double agent in tumor immune resistance

JM David, C Dominguez, DH Hamilton, C Palena - Vaccines, 2016 - mdpi.com
Interleukin-8 (IL-8, CXCL8) is a pro-inflammatory chemokine produced by various cell types
to recruit leukocytes to sites of infection or tissue injury. Acquisition of IL-8 and/or its …

[HTML][HTML] Beyond cell motility: the expanding roles of chemokines and their receptors in malignancy

D Morein, N Erlichman, A Ben-Baruch - Frontiers in immunology, 2020 - frontiersin.org
The anti-tumor activities of some members of the chemokine family are often overcome by
the functions of many chemokines that are strongly and causatively linked with increased …

[HTML][HTML] The CXCL8-CXCR1/2 pathways in cancer

Q Liu, A Li, Y Tian, JD Wu, Y Liu, T Li, Y Chen… - Cytokine & growth factor …, 2016 - Elsevier
Persistent infection or chronic inflammation contributes significantly to tumourigenesis and
tumour progression. CXC motif ligand 8 (CXCL8) is a chemokine that acts as an important …

Phase Ib pilot study to evaluate reparixin in combination with weekly paclitaxel in patients with HER-2–negative metastatic breast cancer

AF Schott, LJ Goldstein, M Cristofanilli, PA Ruffini… - Clinical Cancer …, 2017 - AACR
Abstract Purpose: Chemokine receptor 1 (CXCR1) is recognized as an actionable receptor
selectively expressed by breast cancer stem cells (BCSCs). Reparixin is an investigational …

[HTML][HTML] The challenge of targeting cancer stem cells to halt metastasis

A Agliano, A Calvo, C Box - Seminars in Cancer Biology, 2017 - Elsevier
Despite a continuing debate about the existence of cancer stem cells (CSCs), recent
discoveries have provided further support for their existence and their roles in drug …

Epithelial-mesenchymal transition and inflammation at the site of the primary tumor

C Dominguez, JM David, C Palena - Seminars in cancer biology, 2017 - Elsevier
Tumor growth and progression are the products of complex signaling networks between
different cell types within the tumor and its surrounding stroma. In particular, established …